Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bristol-Myers Squibb | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Bristol-Myers Squibb

CFO Jean-Marc Huet plans to leave BMS at the end of 2009.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles Bancroft has been appointed acting chief financial officer of Bristol-Myers Squibb, effective January 1, 2010. Jean-Marc Huet, executive vice president and chief financial officer, will leave the company at the end of 2009.

“Jean-Marc has indicated to me his desire to return to Europe and we wish him every success,” said James M. Cornelius, chairman and chief executive officer of BMS. “The board of directors and I are grateful to Jean-Marc for his strategic work in rapidly and successfully solidifying our balance sheet, his focus on increasing our cash position to nearly $10 billion through a series of important transactions, and his leadership of continuous improvement initiatives which have greatly accelerated our BioPharma transformation.”

Mr. Bancroft was most recently vice president, finance for BMS’s global biopharmaceutical business. In his new role, he will continue to report to Lamberto Andreotti, president and chief operating officer.

Mr. Bancroft joined the company in 1984 and has since held positions of increasing responsibility within the finance organization, including international assignments, senior leadership positions in the global pharmaceutical business and also with ConvaTec.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters